SK2072003A3 - Process for making N-aryl-anthranilic acids and their derivatives - Google Patents

Process for making N-aryl-anthranilic acids and their derivatives Download PDF

Info

Publication number
SK2072003A3
SK2072003A3 SK207-2003A SK2072003A SK2072003A3 SK 2072003 A3 SK2072003 A3 SK 2072003A3 SK 2072003 A SK2072003 A SK 2072003A SK 2072003 A3 SK2072003 A3 SK 2072003A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
alkyl
hydrogen
aryl
Prior art date
Application number
SK207-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Michael Huai Gu Chen
Edward Mark Davis
Javier Magano
Thomas Norman Nanninga
Derick Dale Winkle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SK2072003A3 publication Critical patent/SK2072003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
SK207-2003A 2000-08-25 2001-07-20 Process for making N-aryl-anthranilic acids and their derivatives SK2072003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25
PCT/US2001/022948 WO2002018319A1 (en) 2000-08-25 2001-07-20 Process for making n-aryl-anthranilic acids and their derivatives

Publications (1)

Publication Number Publication Date
SK2072003A3 true SK2072003A3 (en) 2004-01-08

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
SK207-2003A SK2072003A3 (en) 2000-08-25 2001-07-20 Process for making N-aryl-anthranilic acids and their derivatives

Country Status (32)

Country Link
EP (1) EP1313694A1 (is)
JP (1) JP2004507518A (is)
KR (1) KR20030059115A (is)
CN (1) CN1458921A (is)
AP (1) AP2001002249A0 (is)
AR (1) AR032175A1 (is)
AU (1) AU2001277044A1 (is)
BG (1) BG107635A (is)
BR (1) BR0113520A (is)
CA (1) CA2420003A1 (is)
CZ (1) CZ2003477A3 (is)
DO (1) DOP2001000238A (is)
EA (1) EA200300187A1 (is)
GT (1) GT200100174A (is)
HN (1) HN2001000216A (is)
HU (1) HUP0300828A2 (is)
IL (1) IL154507A0 (is)
IS (1) IS6724A (is)
MA (1) MA26949A1 (is)
MX (1) MXPA03001654A (is)
NO (1) NO20030844L (is)
PA (1) PA8526501A1 (is)
PE (1) PE20020393A1 (is)
PL (1) PL360699A1 (is)
PY (1) PY0120841A (is)
SK (1) SK2072003A3 (is)
SV (1) SV2002000601A (is)
TN (1) TNSN01127A1 (is)
UY (1) UY26908A1 (is)
WO (1) WO2002018319A1 (is)
YU (1) YU14303A (is)
ZA (1) ZA200301182B (is)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100984595B1 (ko) 2002-03-13 2010-09-30 어레이 바이오파마 인크. Ｍｅｋ 억제제로서의 ｎ3 알킬화 벤즈이미다졸 유도체
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
NZ546011A (en) 2003-10-21 2009-09-25 Warner Lambert Co Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
CN1905873A (zh) 2003-11-19 2007-01-31 阵列生物制药公司 Mek的杂环抑制剂及其使用方法
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
NZ590160A (en) 2003-11-21 2012-07-27 Array Biopharma Inc AKT protein kinase inhibitors
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
JP5154406B2 (ja) 2005-04-13 2013-02-27 アステックス、セラピューティックス、リミテッド 医薬化合物
ES2405785T3 (es) 2005-05-18 2013-06-03 Array Biopharma Inc. Inhibidores heterocíclicos de MEK y métodos de uso de los mismos
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
ATE523499T1 (de) 2006-07-06 2011-09-15 Array Biopharma Inc Cyclopenta [d]-pyrimidine als akt-proteinkinasehemmer
ATE532789T1 (de) 2006-07-06 2011-11-15 Array Biopharma Inc Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
CA2656566C (en) 2006-07-06 2014-06-17 Array Biopharma Inc. Dihydrofuro pyrimidines as akt protein kinase inhibitors
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
EP2073802A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
JP5410285B2 (ja) 2006-10-12 2014-02-05 アステックス、セラピューティックス、リミテッド 医薬化合物
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
WO2009006567A2 (en) 2007-07-05 2009-01-08 Array Biopharma Inc. Pyrimidyl cyclopentanes as akt protein kinase inhibitors
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101918373B (zh) 2007-07-05 2013-06-05 阵列生物制药公司 作为akt蛋白激酶抑制剂的嘧啶基环戊烷
ES2422733T3 (es) 2008-01-09 2013-09-13 Array Biopharma Inc Pirimidilciclopentanos hidroxilados como inhibidores de proteínas cinasas AKT
EP2240455B1 (en) 2008-01-09 2012-12-26 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
JP2013519714A (ja) * 2010-02-19 2013-05-30 センター ナショナル デ ラ リシェルシェ サイエンティフィック 芳香族求核置換によって目的の化学化合物を調製するための方法
CN102985399A (zh) * 2010-02-19 2013-03-20 国家科学研究中心 通过对携带至少一个吸电子基团的芳香族羧酸衍生物进行亲核芳香族取代来制备目的化合物的方法
WO2012135781A1 (en) 2011-04-01 2012-10-04 Genentech, Inc. Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
RU2013148817A (ru) 2011-04-01 2015-05-10 Дженентек, Инк. Комбинации соединений-ингибиторов акт и мек и способы их применения
KR102204520B1 (ko) * 2012-10-12 2021-01-20 엑셀리시스, 인코포레이티드 암의 치료에 사용하기 위한 화합물의 신규 제조 방법
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用
CN119948008B (zh) * 2022-07-15 2026-04-28 南方科技大学 一种以异腈和环丙烯为原料制备稠环芳胺的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
AU5610398A (en) * 1997-02-28 1998-09-18 Warner-Lambert Company Method of treating or preventing septic shock by administering a mek inhibitor
NZ501276A (en) * 1997-07-01 2000-10-27 Warner Lambert Co 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
BR9810385A (pt) * 1997-07-01 2000-09-05 Warner Lambert Co Derivados de ácido benzóico 2-(4-bromo ou 4-iodo fenilamino) e sua utilização como inibidores de mek
CA2348236A1 (en) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
PT1171418E (pt) * 1999-04-21 2005-02-28 Warner Lambert Co Metodo de preparacao de acidos 2-(n-fenilamino)benzoicos

Also Published As

Publication number Publication date
JP2004507518A (ja) 2004-03-11
YU14303A (sh) 2006-08-17
BG107635A (bg) 2004-09-30
NO20030844D0 (no) 2003-02-24
PA8526501A1 (es) 2002-07-30
BR0113520A (pt) 2003-06-24
TNSN01127A1 (en) 2005-11-10
HUP0300828A2 (hu) 2003-09-29
WO2002018319A1 (en) 2002-03-07
HN2001000216A (es) 2002-05-22
PL360699A1 (en) 2004-09-20
PY0120841A (es) 2004-06-01
CN1458921A (zh) 2003-11-26
KR20030059115A (ko) 2003-07-07
ZA200301182B (en) 2004-05-12
AU2001277044A1 (en) 2002-03-13
CZ2003477A3 (cs) 2003-10-15
EP1313694A1 (en) 2003-05-28
GT200100174A (es) 2002-07-18
DOP2001000238A (es) 2003-01-31
PE20020393A1 (es) 2002-05-09
SV2002000601A (es) 2002-04-03
MXPA03001654A (es) 2004-09-10
MA26949A1 (fr) 2004-12-20
AP2001002249A0 (en) 2001-09-30
AR032175A1 (es) 2003-10-29
IS6724A (is) 2003-02-20
NO20030844L (no) 2003-02-25
CA2420003A1 (en) 2002-03-07
EA200300187A1 (ru) 2003-08-28
IL154507A0 (en) 2003-09-17
UY26908A1 (es) 2001-11-30

Similar Documents

Publication Publication Date Title
SK2072003A3 (en) Process for making N-aryl-anthranilic acids and their derivatives
JP6966590B2 (ja) オメカムチブメカルビルの塩及び塩を調製するプロセス
JP7664971B2 (ja) エドキサバンの製造方法
US20130060038A1 (en) Preparation of dihydropyrrol derivatives as intermediates
EP2409967A1 (en) Polymorphs of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
US20190330206A1 (en) New compound and process
WO2004072030A2 (en) Process for preparing pyrrolotriazine kinase inhibitors
US20160355486A1 (en) Methods of making protein deacetylase inhibitors
US20040039208A1 (en) Process for making n-aryl-anthranilic acids and their derivatives
CN102137672B (zh) 取代的嘧啶衍生物的制备方法
CA2543250C (en) Process for the preparation of ccr-2 antagonist
CN107810189B (zh) 用于制备氮芥衍生物的方法
CN110612291A (zh) 2-([1,2,3]三唑-2-基)-苯甲酸衍生物的制备
JP4537499B2 (ja) エプロサルタンの製造方法
US6770763B2 (en) Asymmetric synthesis of amino-pyrrolidinones
US7872141B2 (en) Processes for the manufacture of a pyrrolidine-3,4-dicarboxamide derivative
ES2536404T3 (es) Procedimiento para la preparación de ésteres de azoniaspironortropina
KR101123281B1 (ko) 치환된 벤즈아미드 유도체 및 그의 약제학상 허용되는 염의제조방법
CA3214107A1 (en) New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds
CN101506146B (zh) 3-氨基-5-氟-4-二烷氧基戊酸酯的制备方法
CN119613311A (zh) 一种（3s,4r）-3-（n-苄基-n-环丙基）氨甲基-4-羟基吡咯烷-1-羧酸苄酯的高选择性合成方法
JP2641879B2 (ja) 光学活性を有するヒダントイン誘導体の製法
NZ736564B2 (en) Process for preparation of nitrogen mustard derivatives
EP1634879A1 (en) Method of selectively introducing amino substituent
HK1250732B (en) Process for preparation of nitrogen mustard derivatives